SCHEMBL7363502

SCHEMBL7363502

COC(=O)CCc1ccc(N=C=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
CYP4F2 P78329 3/20 0.47
CYP4A11 Q02928 3/20 0.47
CYP4Z1 Q86W10 1/20 0.46
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
F2RL1 P55085 1/20 0.42
IDO1 P14902 1/20 0.42
EPHX2 P34913 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CA12 O43570 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3763772 0.86 P2RY6 (0.58) CYP4F2CYP4A11CYP4Z1ADRB2ADRB1
SCHEMBL3306612 0.83 CYP4F2 (0.59) CYP3A4TSHRCYP4F2CYP4A11CYP4Z1
SCHEMBL22922181 0.82 CYP4F2 (0.59) TSHRCYP4F2CYP4A11ADRB2ADRB1
SCHEMBL3679325 0.79 CYP4A11 (0.72) TSHRCYP4F2CYP4A11ADRB2ADRB1
SCHEMBL8879639 0.78 CYP4F2 (0.50) TSHRCYP4F2CYP4A11ADRB2ADRB1
SCHEMBL733010 0.76 CYP3A4 (0.74) CYP3A4TSHRCA12CA7CA9
SCHEMBL23665870 0.76 IDO1 (0.47) CYP4F2CYP4A11CYP4Z1ADRB2ADRB1
SCHEMBL14864574 0.76 CYP4Z1 (0.45) CYP4F2CYP4A11CYP4Z1ADRB2ADRB1
SCHEMBL693698 0.76 CYP4F2 (0.49) TSHRCYP4F2CYP4A11CYP4Z1ADRB2
SCHEMBL11158755 0.76 CYP4Z1 (0.62) CYP3A4TSHRCYP4F2CYP4A11CYP4Z1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827849-A HAVING INHIBITORY EFFECT ON INFLAMMATION AND BONE DEGRADATION, ANTITHROMBOTIC, ANTIAGGREGATORY AND TUMOR- OR METASTASIS-INHIBITING EFFECT KARL THOMAE GMBH (DE) 1998-10-27 US disclosed
EP-0612741-B1 Cyclic derivatives, medicaments containing them and process for their preparation THOMAE GMBH DR K (DE) 1998-06-10 EP disclosed
US-5612335-A ANTICOAGULANTS; COMBATING/PREVENTING DISEASES WHERE CELL AGGREGATES OCCUR OR CELL-MATRIX INTERACTIONS PLAY A PART KARL THOMAE GMBH (DE) 1997-03-18 US disclosed
US-5519036-A IMIDAZOLIDINONES, ANTICOAGULANTS, CELL AGGREGATION PREVENTION KARL THOMAE GMBH (DE) 1996-05-21 US disclosed
WO-1996002514-A1 UREA AND CARBAMIC ACID DERIVATIVES, DRUGS CONTAINING THESE COMPOUNDS, AND PROCESS FOR THEIR PREPARATION DR. KARL THOMAE GMBH (DE) 1996-02-01 WO disclosed
WO-1995024405-A1 IMIDAZOLIDIN-2-ONES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD OF PREPARING THEM DR. KARL THOMAE GMBH (DE) 1995-09-14 WO disclosed
EP-0612741-A1 Cyclic derivatives, medicaments containing them and process for their preparation Dr. Karl Thomae GmbH (DE) 1994-08-31 EP disclosed